Actinium Pharmaceuticals Stock Price on July 25, 2018
ATNM Stock | USD 8.96 0.21 2.40% |
Below is the normalized historical share price chart for Actinium Pharmaceuticals extending back to June 02, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Actinium Pharmaceuticals stands at 8.96, as last reported on the 7th of May, with the highest price reaching 9.20 and the lowest price hitting 8.54 during the day.
If you're considering investing in Actinium Stock, it is important to understand the factors that can impact its price. Actinium Pharmaceuticals is slightly risky given 3 months investment horizon. Actinium Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.08% are justified by taking the suggested risk. Use Actinium Pharmaceuticals Risk Adjusted Performance of 0.0998, mean deviation of 4.44, and Downside Deviation of 5.02 to evaluate company specific risk that cannot be diversified away.
At this time, Actinium Pharmaceuticals' Issuance Of Capital Stock is very stable compared to the past year. As of the 7th of May 2024, Stock Based Compensation To Revenue is likely to grow to 49.80, while Common Stock Total Equity is likely to drop about 24 K. . At this time, Actinium Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 7th of May 2024, Price Book Value Ratio is likely to grow to 3.90, while Price Earnings To Growth Ratio is likely to drop (0.08). Actinium Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of December 2012 | 200 Day MA 6.2552 | 50 Day MA 7.9374 | Beta 0.076 |
Actinium |
Sharpe Ratio = 0.1719
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ATNM | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.3 actual daily | 55 55% of assets are less volatile |
Expected Return
1.08 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Actinium Pharmaceuticals is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Actinium Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 7.2725 | Enterprise Value Ebitda (3.72) | Price Sales 3.3 K | Shares Float 29 M | Wall Street Target Price 25.47 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Actinium Pharmaceuticals Stock history
Actinium Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Actinium is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Actinium Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Actinium Pharmaceuticals stock prices may prove useful in developing a viable investing in Actinium Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 26.6 M | 27.9 M | |
Net Loss | -29.7 M | -31.2 M |
Actinium Pharmaceuticals Quarterly Net Working Capital |
|
Actinium Pharmaceuticals Stock Technical Analysis
Actinium Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Actinium Pharmaceuticals Period Price Range
Actinium Pharmaceuticals May 7, 2024 Market Strength
Market strength indicators help investors to evaluate how Actinium Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Actinium Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Actinium Pharmaceuticals stock market strength indicators, traders can identify Actinium Pharmaceuticals entry and exit signals to maximize returns
Actinium Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Actinium Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Actinium Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Actinium to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0998 | |||
Jensen Alpha | 0.8155 | |||
Total Risk Alpha | 0.2454 | |||
Sortino Ratio | 0.1656 | |||
Treynor Ratio | 0.7182 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Actinium Stock analysis
When running Actinium Pharmaceuticals' price analysis, check to measure Actinium Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinium Pharmaceuticals is operating at the current time. Most of Actinium Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Actinium Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinium Pharmaceuticals' price. Additionally, you may evaluate how the addition of Actinium Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Actinium Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 0.003 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (0.92) |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.